Clinical aspects of invasive candidiasis in critically ill patients

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Mycology

Background:

• Invasive candidiasis is a significant cause of illness and death among intensive care unit (ICU) patients.
• Candida species are a common source of hospital-acquired infections, particularly in immunocompromised individuals.

Purpose of the Study:

• To review the epidemiology and clinical impact of invasive candidiasis in critically ill patients.
• To discuss diagnostic challenges, risk stratification, and preventive strategies for fungal infections in the ICU.
• To evaluate current and emerging antifungal therapies for invasive candidiasis.

Main Methods:

• Literature review of studies on invasive candidiasis in ICU settings.
• Analysis of epidemiological data, mortality rates, and diagnostic approaches.
• Evaluation of prophylactic, pre-emptive, and therapeutic antifungal strategies.

Main Results:

• Invasive candidiasis significantly increases morbidity and mortality in ICU patients.
• Accurate and timely diagnosis remains a challenge.
• Prophylaxis, pre-emptive treatment, and appropriate antifungal selection are crucial.

Conclusions:

• Effective management of invasive candidiasis in ICUs requires a multifaceted approach.
• Newer antifungal agents, including novel azoles and echinocandins, offer improved treatment options.
• Continued research into early detection and targeted therapy is essential.